Targiniq Er

Active Ingredient(s): Oxycodone Hydrochloride + Naloxone Hydrochloride
FDA Approved: * July 23, 2014
Pharm Company: * PURDUE PHARMA LP
Category: Pain Relief

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Targiniq Er Overview

Oxycodone/naloxone is a combination analgesic drug available as modified-release tablets under the trade names Targin (produced by Mundipharma), Targiniq and Targinact. The oxycodone component is an opioid and is responsible for the pain-relieving effects. Naloxone opposes the effects of opioids but is poorly absorbed into the body when given orally, meaning almost all the dose stays within the gastrointestinal tract and reduces the local side effects from the oxycodone. Constipation was sign...

Read more Targiniq Er Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Oxycodone/naloxone

Recent Targiniq Er Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Drugs with one or more similar ingredients: (6 results)

• OXYCODONE + NALOXONE 1 discussion
• EVZIO Naloxone Hydrochloride
• OXECTA Oxycodone Hydrochloride4 discussions
• ROXYBOND Oxycodone Hydrochloride
• TROXYCA ER Oxycodone Hydrochloride + Naltrexone Hydrochloride
• XARTEMIS XR Oxycodone Hydrochloride + Acetaminophen7 discussions

Related Targiniq Er Topics: